Skip to main content

Table 2 Correlation between immunohistochemical analysis and molecular methods

From: Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients?

 

Sanger sequencing

Cobas® test

Pyrosequencing

positive

negative

positive

negative

positive

negative

IHC

positive

4

1

23

0

6

0

negative

2

14

2

4

0

7

Total

 

6

15

25

4

6

7

Concordance

85.7% (k = 0.632)

93.1% (k = 0.760)

100% (k = 1)

  1. IHC immunohistochemistry
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us